Why choose richmond pharmacology for early phase studies? Since 2001, Richmond Pharmacology has conducted over 500 Early Phase Studies, delivering exceptional customer service, and exceeding the expectations of our sponsors. We have significant experience in running a range of patient trials, adding value to the studies by incorporating detailed analysis of the cardiovascular effects of drugs.Why sponsor a richmond pharmacology trial? As a sponsor, you will receive a personal and truly strategic experience and our knowledgeable staff will ensure your trial delivers meaningful results. Our business is sustainable, adaptive to change and is led by the same specialists who founded Richmond Pharmacology nineteen years ago.
Richmond Pharmacology is a full service clinical research organisation based in London, UK. Founded in 2001 Richmond Pharmacology is led by its three founding directors Dr Jorg Taubel, CEO; Dr Ulrike Lorch, Medical Director and Dr Radivoj Arezina, Research Director whose experience has been gained in more than 500 clinical trials.
20 7042 5808 For more information on how we can enhance your global development contact us at: [email protected] or speak to our BD Team on +44 (0) 20 7042 5808 Richmond Pharmacology’s recruitment database is the largest in Europe containing a panel of over 7,000 1st generation Japanese volunteers